Phase 2 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to sign a consent form and follow the trial schedule, including visits, treatments, and lab tests
- Your physical fitness level is rated 0 or 1 on a standard activity scale (meaning you are fully active or have only minor limitations in strenuous activity)
- You have been diagnosed with esophageal cancer in the chest area, confirmed by a tissue sample, and your cancer is at a specific stage that has not spread to distant parts of the body (confirm with trial site for exact staging)
- You have at least one measurable area of cancer that can be tracked during the trial
- A tissue sample from your tumor is available for a specific protein test (called PD-L1 testing)
- Your doctors have determined that your overall health can safely support esophageal surgery
- You are between 18 and 75 years old
- If you are a woman who could become pregnant, you must have a negative pregnancy test within 24 hours before starting treatment
- You must not be breastfeeding if you are a woman
Who may not be able to join:
- Your cancer has spread to other parts of the body or cannot be surgically removed
- You have moderate or severe nerve damage in your hands or feet (Grade 2 or higher peripheral neuropathy)
- You have an active autoimmune disease (a condition where your immune system attacks your own body) — some milder conditions like type 1 diabetes, underactive thyroid managed with hormones only, or certain skin conditions may still be allowed (confirm with trial site)
- You are currently taking high-dose steroid medicines or other drugs that suppress your immune system (with some exceptions — confirm with trial site)
- You have HIV or AIDS
- You have received previous chest radiation, chemotherapy, immunotherapy, or surgery involving your esophagus or stomach before joining the trial
- You have serious heart or lung disease, or a history of a lung condition called interstitial pneumonia
- You have significant esophageal ulcers, severe chest or back pain, or signs of a hole in your esophagus
- Your blood test results fall outside of safe ranges, including low white blood cells, low platelets, low red blood cells, or poor kidney or liver function (confirm with trial site for specific numbers)
- You have active hepatitis B or hepatitis C infections (some people with past infections may still qualify — confirm with trial site)
- You have had another cancer within the past 3 years, with some exceptions for certain easily treated skin or surface cancers
- You have a known allergy or sensitivity to any of the medicines used in this trial
- You have an active infection requiring treatment within 14 days before starting the trial
- You are unable or unwilling to understand and follow the trial requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Qixun Chen, Zhejiang Cancer Hospital
Phone: +86-13958108371
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
1-year DFS of CCR-Watch and Wait group
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.